TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -14.75%775.65M | 110.98%2.36B | 149.08%909.82M | 19.20%1.12B | 0.88%365.27M | -6.47%936.6M | 1.17%362.07M | 11.58%1B | 21.40%357.89M | 10.88%897.49M |
Operating income | -14.75%775.65M | 110.98%2.36B | 149.08%909.82M | 19.20%1.12B | 0.88%365.27M | -6.47%936.6M | 1.17%362.07M | 11.58%1B | 21.40%357.89M | 10.88%897.49M |
Cost of sales | 21.42%-600.29M | -106.42%-1.9B | -143.37%-763.89M | -27.20%-922.69M | -11.75%-313.87M | 4.93%-725.37M | -3.88%-280.88M | -14.89%-763M | -21.52%-270.38M | -8.32%-664.12M |
Operating expenses | 21.42%-600.29M | -106.42%-1.9B | -143.37%-763.89M | -27.20%-922.69M | -11.75%-313.87M | 4.93%-725.37M | -3.88%-280.88M | -14.89%-763M | -21.52%-270.38M | -8.32%-664.12M |
Gross profit | 20.16%175.36M | 132.69%450.85M | 183.96%145.93M | -8.27%193.75M | -36.71%51.39M | -11.41%211.23M | -7.21%81.2M | 2.17%238.43M | 21.02%87.51M | 18.85%233.37M |
Selling expenses | -65.66%-12.46M | 0.19%-18.8M | 7.93%-7.52M | 32.97%-18.84M | 16.29%-8.17M | -114.28%-28.1M | -116.46%-9.76M | 7.75%-13.11M | 21.90%-4.51M | 4.13%-14.22M |
Administrative expenses | 10.12%-38.02M | -5.59%-91.67M | -12.48%-42.3M | -15.63%-86.81M | -17.54%-37.61M | -10.66%-75.08M | -10.15%-32M | -8.98%-67.84M | -14.90%-29.05M | -31.47%-62.25M |
Impairment and provision | -145.90%-60.01M | 20.47%-110.13M | 57.64%-24.4M | -115.58%-138.48M | -329.94%-57.61M | -59.02%-64.23M | 9.09%-13.4M | 37.25%-40.39M | -768.99%-14.74M | -130.37%-64.37M |
-Other impairment is provision | -145.90%-60.01M | 20.47%-110.13M | 57.64%-24.4M | -115.58%-138.48M | -329.94%-57.61M | -59.02%-64.23M | 9.09%-13.4M | 37.25%-40.39M | -768.99%-14.74M | -130.37%-64.37M |
Special items of operating profit | 67.45%7.16M | 23.16%10.55M | -8.70%4.27M | -63.39%8.57M | -18.52%4.68M | 135.03%23.4M | 48.35%5.74M | -28.36%9.96M | -46.08%3.87M | -28.19%13.9M |
Operating profit | -5.20%72.04M | 676.05%240.81M | 260.62%75.99M | -162.18%-41.8M | -248.82%-47.31M | -47.09%67.22M | -26.22%31.79M | 19.36%127.04M | -7.82%43.08M | -15.25%106.44M |
Financing cost | 22.79%-24.96M | 6.79%-65.13M | 10.93%-32.33M | -83.86%-69.88M | -110.19%-36.3M | 0.15%-38.01M | 8.79%-17.27M | 7.46%-38.07M | 8.66%-18.93M | -11.20%-41.14M |
Share of profits of associates | -60.02%363K | 134.78%1.37M | -42.24%908K | -411.99%-3.93M | 1,466.96%1.57M | -12.93%1.26M | -109.68%-115K | -70.56%1.45M | -25.61%1.19M | 64.91%4.91M |
Share of profit from joint venture company | -119.71%-298K | -608.34%-4.39M | -57.12%1.51M | -86.78%863K | -33.16%3.53M | -26.87%6.53M | 79.61%5.28M | -2.53%8.93M | -47.83%2.94M | 43.61%9.16M |
Earning before tax | 2.31%47.14M | 250.46%172.65M | 158.69%46.08M | -410.08%-114.75M | -498.89%-78.51M | -62.75%37.01M | -30.40%19.68M | 25.17%99.35M | -14.93%28.28M | -18.97%79.37M |
Tax | -44.20%-3.73M | -207.56%-19.43M | -125.23%-2.59M | 602.25%18.06M | 420.91%10.25M | 88.18%-3.6M | 54.12%-3.19M | -1.64%-30.41M | 34.57%-6.96M | -10.24%-29.92M |
After-tax profit from continuing operations | -0.18%43.41M | 258.47%153.23M | 163.72%43.49M | -389.40%-96.69M | -513.99%-68.26M | -51.54%33.41M | -22.65%16.49M | 39.41%68.94M | -5.68%21.32M | -30.16%49.45M |
Earning after tax | -0.18%43.41M | 258.47%153.23M | 163.72%43.49M | -389.40%-96.69M | -513.99%-68.26M | -51.54%33.41M | -22.65%16.49M | 39.41%68.94M | -5.68%21.32M | -30.16%49.45M |
Minority profit | 43.26%9.15M | 5,322.90%18.02M | 311.91%6.39M | -133.11%-345K | -2,032.69%-3.02M | -133.94%-148K | 23.81%156K | 1,113.95%436K | 200.00%126K | -110.75%-43K |
Profit attributable to shareholders | -7.66%34.26M | 240.34%135.21M | 156.87%37.1M | -387.09%-96.34M | -499.49%-65.24M | -51.01%33.56M | -22.93%16.33M | 38.41%68.51M | -6.06%21.19M | -29.71%49.5M |
Basic earnings per share | -7.69%0.12 | 240.00%0.49 | 154.17%0.13 | -391.67%-0.35 | -500.00%-0.24 | -61.29%0.12 | -40.00%0.06 | 34.78%0.31 | 0.1 | 0.23 |
Diluted earnings per share | -7.69%0.12 | 154.17%0.13 | -500.00%-0.24 | -40.00%0.06 | 34.78%0.31 | 0.1 | 0.23 | |||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.